Citizens Financial Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Buy |
2,250
+521
| +30% | +$292K | 0.01% | 401 |
|
|
2026
Q1 | $972K | Sell |
1,729
-512
| -23% | -$328K | 0.01% | 402 |
|
|
2025
Q4 | $1.52M | Sell |
2,241
-33
| -1% | -$22.5K | 0.02% | 320 |
|
|
2025
Q3 | $1.45M | Buy |
2,274
+666
| +41% | +$404K | 0.02% | 327 |
|
|
2025
Q2 | $863K | Buy |
1,608
+558
| +53% | +$267K | 0.01% | 381 |
|
|
2025
Q1 | $441K | Buy |
1,050
+136
| +15% | +$59.1K | 0.01% | 440 |
|
|
2024
Q4 | $378K | Buy |
914
+61
| +7% | +$26.8K | 0.01% | 438 |
|
|
2024
Q3 | $431K | Buy |
853
+178
| +26% | +$86.5K | 0.01% | 402 |
|
|
2024
Q2 | $329K | Buy |
675
+216
| +47% | +$108K | 0.01% | 435 |
|
|
2024
Q1 | $248K | Sell |
459
-89
| -16% | -$48.6K | 0.01% | 367 |
|
|
2023
Q4 | $304K | Buy |
548
+3
| +0.6% | +$1.41K | 0.01% | 335 |
|
|
2023
Q3 | $238K | Buy |
545
+157
| +40% | +$78.3K | 0.01% | 324 |
|
|
2023
Q2 | $195K | Sell |
388
-252
| -39% | -$121K | 0.01% | 372 |
|
|
2023
Q1 | $320K | Buy |
640
+94
| +17% | +$45K | 0.01% | 358 |
|
|
2022
Q4 | $223K | Buy |
+546
| New | +$212K | 0.01% | 389 |
|
|
2022
Q2 | – | Sell |
-593
| Closed | -$324K | – | 439 |
|
|
2022
Q1 | $324K | Buy |
593
+3
| +0.5% | +$1.58K | 0.01% | 351 |
|
|
2021
Q4 | $360K | Sell |
590
-3
| -0.5% | -$1.88K | 0.01% | 340 |
|
|
2021
Q3 | $369K | Buy |
593
+21
| +4% | +$14.1K | 0.01% | 325 |
|
|
2021
Q2 | $361K | Sell |
572
-22
| -4% | -$12.1K | 0.02% | 279 |
|
|
2021
Q1 | $291K | Buy |
594
+31
| +6% | +$15.5K | 0.02% | 255 |
|
|
2020
Q4 | $281K | Buy |
+563
| New | +$252K | 0.02% | 243 |
|
|
2020
Q3 | – | Sell |
-525
| Closed | -$173K | – | 550 |
|
|
2020
Q2 | $173K | Buy |
525
+183
| +54% | +$53K | 0.01% | 294 |
|
|
2020
Q1 | $83K | Buy |
342
+41
| +14% | +$10.7K | 0.01% | 350 |
|
|
2019
Q4 | $79K | Buy |
+301
| New | +$79.3K | 0.01% | 367 |
|
|
2019
Q1 | – | Sell |
-28
| Closed | -$5K | – | 763 |
|
|
2018
Q4 | $5K | Buy |
+28
| New | +$5.74K | ﹤0.01% | 439 |
|
|
2017
Q2 | – | Sell |
-801
| Closed | -$124K | – | 568 |
|
|
2017
Q1 | $124K | Sell |
801
-12
| -1% | -$1.65K | 0.01% | 273 |
|
|
2016
Q4 | $95K | Hold |
813
| – | – | 0.01% | 299 |
|
|
2016
Q3 | $92K | Sell |
813
-4
| -0.5% | -$422 | 0.01% | 305 |
|
|
2016
Q2 | $76K | Buy |
817
+50
| +7% | +$4.29K | 0.01% | 328 |
|
|
2016
Q1 | $61K | Buy |
767
+7
| +0.9% | +$504 | 0.01% | 347 |
|
|
2015
Q4 | $55K | Buy |
+760
| New | +$54.2K | 0.01% | 362 |
|
Other funds holding IDXX
Citizens Financial Group's IDXX Position: Q2 2026 in Review
Citizens Financial Group increased its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, buying an estimated $292K and bringing the position to 2,250 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #401.
Citizens Financial Group first reported a position in IDXX in Q4 2015 and has held it in 31 quarters since. The position peaked at $1.52M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Citizens Financial Group held 2,250 shares of Idexx Laboratories worth $1.18M as of Q2 2026.
- Citizens Financial Group bought 521 Idexx Laboratories shares in Q2 2026, an estimated $292K.
- Idexx Laboratories made up 0.01% of Citizens Financial Group's portfolio in Q2 2026, its #401 holding.
- Citizens Financial Group first reported a position in Idexx Laboratories in Q4 2015 and has held it in 31 quarters since.
- Citizens Financial Group's Idexx Laboratories position peaked at $1.52M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.